Market Analysis
Infertility
problems have become quite common these days and there are a couple of reasons
that is resulting in infertility including psychological, immunological,
diseases, drugs or congenital. This is a difficult condition to face and
handle. There are however various assisted reproductive technology (ART)
treatments that are available which help to handle such situation and also
solve it. ART is a biotechnologically advanced and complex technique that can
aid a couple to conceive after all other surgical corrective and conventional
medical procedures have failed. It comprises of treatments where the human
gametes will be handled outside the human body to attain a pregnancy. ART is a
cluster of an array of techniques that helps to treat infertility such as in
vitro fertilization (IVF), fertility medication, cryopreservation of embryos or
gametes and intracytoplasmic sperm injection (ICSI). Assisted Reproductive
Technology falls under the reproductive endocrinology field.
The global assisted
reproductive technology market share is anticipated to grow at a stellar
10% CAGR during the forecast period (2018-2023).
Get Sample Report
@https://www.marketresearchfuture.com/sample_request/6359
Key Players
Leading players profiled in
the assisted reproductive technology market
include Hamilton Throne Ltd, Irvine Scientific, European
Sperm Bank, Ferring Pharmaceuticals, Cooper Surgical, Inc, Merck KGaA, Microm
Ltd., Origio, Anecova, OvaScience, Parallabs, Cryolab Ltd., Bloom IVF Centre, California
Cryobank and California Cryobank.
Market Segmentation
Market Research Future report
offers a comprehensive segmental analysis of theassisted reproductive technology market on the basis of diagnosis, type
and end-user.
Based on diagnosis, it is
segmented into genetic testing, ovarian reserve testing, hysterosalpingography,
ovulation testing and other imaging tests and hormone testing.
Based on type, the assisted reproductive technology market is segmented
into Surrogacy, Preimplantation Genetic Diagnosis (PGD), Intracytoplasmic Sperm
Injection (ICSI), Gamete Intrafallopian Transfer (GIFT), In-Vitro Fertilization
(IVF), Donor Conception, Artificial Insemination (AI) and Ovulation Induction
(OI). Of these, the IVF segment will have the largest share in the market
during the forecast period.
Based on
end-user, it is segmented into IVF Centers, feminist health centers, gynecology
centers, diagnostic centers, ambulatory surgical centers, hospitals and
clinics. Of these, clinics will dominate the market during the forecast period.
Regional Analysis
Based on region, the assisted reproductive technology market covers growth opportunities and latest
trends across the Americas, Europe, Asia Pacific and the Middle East and
Africa. Of these, Europe will remain at the vanguard in assisted reproductive technology market due to growing healthcare
expenditure and rising prevalence of obesity. The assisted reproductive
technology market in the Americas will hold the second major share owing to the
rising incidences of ovarian cancer here. In the APAC region, the assisted
reproductive technology market is expected to grow at the fastest pace owing to
a couple of factors namely increasing incidences of diabetes especially in
women, growing obesity amid the female generation and changing lifestyle. On
the other hand, the assisted reproductive technology market in the Middle East
and Africa will account for a minimal share during the forecast period owing to
low per capita income coupled with stringent government policies.
Feb 2019- Renowned science & technology company,
Merck has lately introduced its pioneering fertility technology. It has
launched two devices- Gems, and Geri and Gavi which will be made accessible in
hospitals and IVF clinics in partnership with GeneaBiomedx. This latest
technology will offer an environment which will help to decrease external
stress on a patient’s embryo that is undergoing fertility treatment. The
cutting-edge technology promises to increase precision, optimize IVF results
for patients and decrease manual labor.
Browse Complete
Report Details @ https://www.marketresearchfuture.com/reports/assisted-reproductive-technology-market-6359
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
The Wall